뒤로
Chemomab Therapeutics Ltd(CMMB) 가격
CMMB 주가 차트
CMMB 재무
Chemomab Therapeutics Ltd
$1.51
2.02%
$0.03
종가: Feb 13, 16:00:00 GMT-5
$1.53
1.32%
$0.02
애프터마켓: Feb 13, 20:00:00 GMT-5
수입
자산 및 부채 명세서
현금 흐름
연간
분기별
CMMB 소득
미화 수백만 달러. 회계 연도는 2월부터 1월까지입니다.
Follow-Up Questions
Chemomab Therapeutics Ltd의 주요 재무제표는 무엇인가요?
CMMB의 주요 재무 비율은 무엇인가요?
Chemomab Therapeutics Ltd의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Chemomab Therapeutics Ltd은 수익성이 있나요?
Chemomab Therapeutics Ltd에 부채가 있나요?
Chemomab Therapeutics Ltd의 발행 주식은 몇 주인가요?
주요 통계
이전 종가
$1.48
시가
$1.5
일일 범위
$1.47 - $1.55
52주 범위
$1.42 - $8.24
거래량
33.7K
평균 거래량
81.5K
EPS(TTM)
-0.07
배당수익률
--
시가총액
$28.8M
CMMB란 무엇인가요?
Chemomab Therapeutics Ltd. is a clinical-stage biotech company, which engages in the provision of therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The firm specializes in the development of patient oriented targeted therapy for the treatment of a wide range of fibrotic and inflammatory diseases with high unmet medical need among others. Its therapeutic and diagnostic technology, BC-819, constitutes a search paradigm for the targeted destruction of cancer cells with no effect on surrounding tissue and no observed side effects for long-term, safe treatment and prevention of cancer. The patient oriented targeted therapy approach is based on the identification of particular genes that are expressed only in tumors.